Butt, Sedrah ArifLidegaard, ØjvindSkovlund, Charlotte W.Hannaford, PhilipIversen, LisaFielding, ShonaMørch, Lina S.2018-11-012018-11-012018-10-30Butt, S A, Lidegaard, Ø, Skovlund, C W, Hannaford, P, Iversen, L, Fielding, S & Mørch, L S 2018, 'Hormonal contraceptive use and risk of pancreatic cancer : A cohort study among premenopausal women', PloS ONE, vol. 13, no. 10, 0206358. https://doi.org/10.1371/journal.pone.0206358, https://doi.org/10.1371/journal.pone.02147711932-6203http://hdl.handle.net/2164/11362Drs. Mørch and Lidegaard were supported by a grant (No 11645) from the Novo Nordisk Foundation. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the paper; or in the decision to submit the paper for publication. Correction: Hormonal contraceptive use and risk of pancreatic cancer—A cohort study among premenopausal women; Sedrah Arif Butt, Øjvind Lidegaard, Charlotte Skovlund, Philip C. Hannaford, Lisa Iversen, Shona Fielding, Lina Steinrud Mørch; PLOS, Published: March 28, 2019, https://doi.org/10.1371/journal.pone.02147718381755engSDG 3 - Good Health and Well-beingR Medicine (General)Supplementary DataR1Journal article10.1371/journal.pone.02063581310